J. Foucher

发表

Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C.

V. de Lédinghen, P. Couzigou, B. le Bail, 2005, Gastroenterology.

Hepatitis C virus prevention and care for drug injectors: the French approach

V. de Lédinghen, M. Jauffret-Roustide, D. Dhumeaux, 2018, Hepatology, Medicine and Policy.

Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study

V. de Lédinghen, P. Couzigou, B. le Bail, 2005, Gut.

Non-invasive evaluation of liver fibrosis by transient elastography and biochemical markers in elderly inpatients.

V. de Lédinghen, J. Foucher, N. Salles, 2009, Gastroenterologie clinique et biologique.

Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores.

V. de Lédinghen, P. Couzigou, F. Roudot-thoraval, 2009, Journal of hepatology.

Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease

Julien Vergniol, V. Wong, V. de Lédinghen, 2010, Hepatology.

Non-invasive assessment of liver fibrosis with impulse elastography: comparison of Supersonic Shear Imaging with ARFI and FibroScan®.

Julien Vergniol, Michel Montaudon, François Laurent, 2014, Journal of hepatology.

A New Combination of Blood Test and Fibroscan for Accurate Non-Invasive Diagnosis of Liver Fibrosis Stages in Chronic Hepatitis C

Vincent Leroy, Paul Calès, S. Bertrais, 2011, The American Journal of Gastroenterology.

Severe liver fibrosis in the HCV cure era: Major effects of social vulnerability, diabetes, and unhealthy behaviors

V. de Lédinghen, J. Zucman‐Rossi, T. Asselah, 2022, JHEP reports : innovation in hepatology.

Daily or three times a week interferon alfa-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C.

V. de Lédinghen, P. Couzigou, H. Fleury, 2002, Journal of Hepatology.

[Visual field progression in glaucoma: cluster analysis].

J. Foucher, H. Bresson-Dumont, J. Hatton, 2012, Journal francais d'ophtalmologie.

Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C

V. de Lédinghen, Y. Bacq, G. Hunault, 2008, Liver international : official journal of the International Association for the Study of the Liver.

Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest®) and elastography (FibroScan®).

V. de Lédinghen, Y. Ngo, M. Rudler, 2014, Journal of hepatology.

High-dose pegylated interferon-α and ribavirin in nonresponder hepatitis C patients and relationship with IL-28B genotype (SYREN trial).

P. Couzigou, J. Pawlotsky, A. Mallat, 2011, Gastroenterology.

Hepatitis C Patients and Relationship with IL28B Genotype (SYREN Trial)

P. Couzigou, J. Pawlotsky, A. Mallat, 2011 .

989 NEW FIBROSCAN PROBE FOR OBESE PATIENTS. A PILOT STUDY OF FEASIBILITY AND PERFORMANCES IN PATIENTS WITH BMI ≥ 30 kg/m2

V. Rigalleau, L. Sandrin, C. Fournier, 2009 .

Non-steroidal anti-inflammatory drugs and variceal bleeding: a case-control study.

V. de Lédinghen, T. Barrioz, P. Ingrand, 1996, Journal of hepatology.

Liver Stiffness Measurement in Children Using FibroScan: Feasibility Study and Comparison With Fibrotest, Aspartate Transaminase to Platelets Ratio Index, and Liver Biopsy

V. de Lédinghen, L. Sandrin, B. le Bail, 2007, Journal of pediatric gastroenterology and nutrition.

Screening for liver fibrosis by using FibroScan(®) and FibroTest in patients with diabetes.

V. de Lédinghen, H. Gin, V. Rigalleau, 2012, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Outbreak of hepatitis C virus infection during sclerotherapy of varicose veins: long-term follow-up of 196 patients (4535 patient-years).

V. de Lédinghen, P. Couzigou, H. Fleury, 2007, Journal of hepatology.

Diagnostic Value of FibroTest With Normal Serum Aminotransferases

P. Couzigou, L. Castéra, J. Foucher, 2006 .

Controlled attenuation parameter for the diagnosis of steatosis in non‐alcoholic fatty liver disease

V. Wong, H. Chan, B. le Bail, 2016, Journal of gastroenterology and hepatology.

Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations.

V. de Lédinghen, C. Cassinotto, J. Vergniol, 2014, Journal of hepatology.

Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort

V. de Lédinghen, J. Zucman‐Rossi, T. Asselah, 2022, Journal of Cannabis Research.

Long‐term prognosis of patients with metabolic (dysfunction)‐associated fatty liver disease by non‐invasive methods

V. de Lédinghen, D. Dutartre, J. Foucher, 2022, Alimentary pharmacology & therapeutics.

Hepatic Steatosis, Carbohydrate Intake, and Food Quotient in Patients with NAFLD

V. de Lédinghen, H. Gin, V. Rigalleau, 2013, International journal of endocrinology.

Performance of simple fibrosis scores in non-obese patients with nonalcoholic fatty liver disease.

V. Wong, V. de Lédinghen, B. le Bail, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD.

V. de Lédinghen, B. le Bail, C. Bureau, 2019, Journal of hepatology.

Assessment of rewarming methods in unplanned out-of-hospital births from a prospective cohort

B. Leclère, F. Javaudin, E. Montassier, 2020, Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine.

Subclinical proximal tubulopathy in hepatitis B: The roles of nucleot(s)ide analogue treatment and the hepatitis B virus

V. de Lédinghen, D. Thabut, N. Ganne-Carrié, 2020, World journal of hepatology.

Liver fibrosis on account of chronic hepatitis C is more severe in HIV‐positive than HIV‐negative patients despite antiretroviral therapy

V. de Lédinghen, V. Soriano, D. Neau, 2008, Journal of viral hepatitis.

Long‐term prognosis of patients with alcohol‐related liver disease or non‐alcoholic fatty liver disease according to metabolic syndrome or alcohol use

V. de Lédinghen, D. Dutartre, J. Foucher, 2021, Liver international : official journal of the International Association for the Study of the Liver.

Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest™) and transient elastography (FibroScan®).

V. de Lédinghen, E. Schiff, Y. Ngo, 2014, Journal of hepatology.

Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis

V. de Lédinghen, T. Asselah, D. Thabut, 2021, BMC Infectious Diseases.

Fibrosis is worse in HIV-HCV patients with low-level immunodepression referred for HCV treatment than in HCV-matched patients.

D. Neau, B. le Bail, C. Balabaud, 2004, Human pathology.

Modifications of T-lymphocyte subsets before and during interferon and ribavirin treatment for chronic hepatitis C infection.

J. Foucher, E. Legrand, V. Ledinghen, 2005, Viral immunology.

87 Prediction of liver fibrosis in non-alcoholic steatohepatitis (NASH): Risk factors and diagnostic potential of liver elasticity using fibroscan

M. Ziol, M. Beaugrand, N. Afdhal, 2006 .

1197 Incidence, risk factors and treatment of mood disorders associated with peginterferon and ribavirin therapy in patients with chronic hepatitis C: results of a prospective study

P. Couzigou, A. Constant, C. Henry, 2003 .

Neutralizing antibodies to interferon‐α and circulating interferon in patients with chronic hepatitis C non‐responding to pegylated interferon plus ribavirin re‐treated by pegylated interferon‐α‐2a and ribavirin (ANRS HC16 GAMMATRI substudy*)

P. Couzigou, P. Marcellin, G. Chêne, 2010, Journal of medical virology.

Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapy

J. Izopet, D. Roulot, P. Colson, 2009, Journal of medical virology.

Hepatitis B virus genotypes: a retrospective survey in Southwestern France, 1999-2004.

V. de Lédinghen, P. Couzigou, D. Neau, 2007, Gastroenterologie clinique et biologique.

HEPATITIS B VIRUS GENOTYPES: A RETROSPECTIVE SURVEY IN SOUTHWESTERN FRANCE, 1999-2004 ETUDE RETROSPECTIVE DES GENOTYPES DU VIRUS DE L'HEPATITE B EN AQUITAINE, 1999-2004

P. Couzigou, D. Neau, J. Ragnaud, 2007 .

Hepatitis B virus genotypes : a retrospective survey in Southwestern France , 1999-2004 HÉPATITES VIRALES

J. Ragnaud, M. Dupon, F. Dabis, 2007 .

Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection

V. de Lédinghen, V. Soriano, G. Satta, 2009, Journal of viral hepatitis.

Improved diagnostic accuracy of blood tests for severe fibrosis and cirrhosis in chronic hepatitis C

V. de Lédinghen, Y. Bacq, F. Oberti, 2009, European journal of gastroenterology & hepatology.

Pitfalls of liver stiffness measurement: A 5‐year prospective study of 13,369 examinations

V. de Lédinghen, P. Couzigou, L. Castéra, 2010, Hepatology.

Liver stiffness measurement predicts long‐term survival and complications in non‐alcoholic fatty liver disease

V. Wong, G. Wong, J. Foucher, 2019, Liver international : official journal of the International Association for the Study of the Liver.

Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease.

Julien Vergniol, Paul Calès, V. de Lédinghen, 2016, Journal of hepatology.

Effect of ribavirin in genotype 1 patients with hepatitis C responding to pegylated interferon alfa-2a plus ribavirin.

T. Asselah, J. Pawlotsky, D. Ouzan, 2006, Gastroenterology.

Transient elastography and biomarkers for liver fibrosis assessment and follow‐up of inactive hepatitis B carriers

V. de Lédinghen, P. Couzigou, B. le Bail, 2011, Alimentary pharmacology & therapeutics.

Dynamic and Rapid Changes in Viral Quasispecies by Udps in Chronic Hepatitis C Patients Receiving Telaprevir-Based Therapy

V. de Lédinghen, H. Fleury, M. Kann, 2013, Antiviral therapy.

Predictive value of early HCV RNA quantitation for sustained response in nonresponders receiving daily interferon and ribavirin therapy

V. de Lédinghen, P. Couzigou, H. Fleury, 2004, Journal of medical virology.

Non‐invasive tests for fibrosis and liver stiffness predict 5‐year survival of patients chronically infected with hepatitis B virus

T. Asselah, E. Zafrani, D. Guyader, 2013, Alimentary pharmacology & therapeutics.

Diagnosis of liver fibrosis by transient elastography (FibroScan) and non‐invasive methods in Crohn's disease patients treated with methotrexate

V. de Lédinghen, P. Couzigou, F. Zerbib, 2006, Alimentary pharmacology & therapeutics.

Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations

V. de Lédinghen, P. Couzigou, L. Castéra, 2006, European journal of gastroenterology & hepatology.

Epidemiological and phylogenetic evidence for patient‐to‐patient hepatitis C virus transmission during sclerotherapy of varicose veins

V. de Lédinghen, P. Couzigou, H. Fleury, 2005, Journal of medical virology.

Evolutionary history of hepatitis C virus genotype 5a in France, a multicenter ANRS study.

M. Van Ranst, J. Izopet, D. Roulot, 2011, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

FibroScan used in street‐based outreach for drug users is useful for hepatitis C virus screening and management: a prospective study

V. de Lédinghen, J. Foucher, J. Delile, 2009, Journal of viral hepatitis.

Usefulness of noninvasive tests in nodular regenerative hyperplasia of the liver

V. de Lédinghen, P. Couzigou, P. Bioulac-Sage, 2010, European journal of gastroenterology & hepatology.

Feasibility of liver transient elastography with FibroScan® using a new probe for obese patients

V. de Lédinghen, V. Rigalleau, J. Vergniol, 2010, Liver international : official journal of the International Association for the Study of the Liver.

Liver and spleen elastography using supersonic shear imaging for the non-invasive diagnosis of cirrhosis severity and oesophageal varices.

V. de Lédinghen, F. Laurent, M. Montaudon, 2015, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C.

Julien Vergniol, V. de Lédinghen, P. Couzigou, 2011, Gastroenterology.

Evolution of noninvasive tests of liver fibrosis is associated with prognosis in patients with chronic hepatitis C

S. Bertrais, F. Oberti, P. Calès, 2014, Hepatology.

Sexual quality of life is impaired in patients with chronic hepatitis C

J. Vergniol, J. Foucher, V. Ledinghen, 2016, International Journal of Impotence Research.

CLINICAL—LIVER, PANCREAS, AND BILIARY TRACT Noninvasive Tests for Fibrosis and Liver Stiffness Predict 5-Year Outcomes of Patients With Chronic Hepatitis C

P. Couzigou, J. Vergniol, J. Foucher, 2011 .

Interpreting liver stiffness in the cirrhotic range.

C. Balabaud, P. Bioulac-Sage, T. Couffinhal, 2009, Journal of Hepatology.

MR relaxometry in chronic liver diseases: Comparison of T1 mapping, T2 mapping, and diffusion-weighted imaging for assessing cirrhosis diagnosis and severity.

V. de Lédinghen, F. Laurent, H. Cochet, 2015, European journal of radiology.

Cost-Effectiveness of Primary HPV Testing, Cytology and Co-testing as Cervical Cancer Screening for Women Above Age 30 Years

M. Rothberg, Bo Hu, J. Foucher, 2016, Journal of General Internal Medicine.

Liver stiffness measurements for evaluation of central venous pressure in congenital heart diseases

V. de Lédinghen, T. Barnetche, J. Vergniol, 2015, Heart.

[Clinical factors favoring excessive subconjunctival fibroblastic proliferation after glaucoma surgery].

J. Foucher, P. Santiago, H. Bresson-Dumont, 2008, Journal francais d'ophtalmologie.

FibroScan and FibroTest to assess liver fibrosis in HCV with normal aminotransferases

V. de Lédinghen, P. Couzigou, L. Castéra, 2006, Hepatology.

Diagnosis of liver fibrosis using FibroScan and other noninvasive methods in patients with hemochromatosis: a prospective study.

V. de Lédinghen, P. Couzigou, L. Castéra, 2008, Gastroenterologie clinique et biologique.

Liver fibrosis: noninvasive assessment with acoustic radiation force impulse elastography--comparison with FibroScan M and XL probes and FibroTest in patients with chronic liver disease.

Julien Vergniol, V. de Lédinghen, B. le Bail, 2013, Radiology.

Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis C

Gérard Forzy, Julien Vergniol, Laurent Castera, 2009, Hepatology.

Non-invasive assessment of liver fibrosis with transient elastography (FibroScan®): applying the cut-offs of M probe to XL probe.

V. de Lédinghen, K. Leung, H. Chan, 2013, Annals of hepatology.

Liver Stiffness Measurement Using XL Probe in Patients With Nonalcoholic Fatty Liver Disease

V. Wong, H. Chan, A. Chan, 2012, The American Journal of Gastroenterology.

Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan®.

V. Wong, V. de Lédinghen, H. Chan, 2012, Journal of hepatology.

Non‐invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography

J. Vergniol, J. Foucher, V. Ledinghen, 2012, Liver international : official journal of the International Association for the Study of the Liver.

Non-invasive evaluation of liver fibrosis using FibroScan in long-term sustained-virological responder patients after HCV treatment.

V. de Lédinghen, P. Couzigou, L. Castéra, 2008, Gastroenterologie clinique et biologique.

Changes of non‐invasive markers and FibroScan values during HCV treatment

V. de Lédinghen, P. Couzigou, L. Castéra, 2009, Journal of viral hepatitis.

Impact of ribavirin plasma level on sustained virological response in patients treated with pegylated interferon and ribavirin for chronic hepatitis C

V. de Lédinghen, P. Couzigou, D. Breilh, 2009, Alimentary pharmacology & therapeutics.

Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis

V. de Lédinghen, J. Zucman‐Rossi, M. Ronot, 2021, JHEP reports : innovation in hepatology.

Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver disease

V. Wong, V. de Lédinghen, H. Chan, 2019, Gut.

Longitudinal Liver Stiffness Assessment in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy

Xavier Forns, V. de Lédinghen, X. Forns, 2012, PloS one.

88 Assessment of cirrhosis and its severity by fibroscan and biochemical markers in alcoholic patients

P. Couzigou, L. Castéra, J. Foucher, 2006 .

Probability-Based Interpretation of Liver Stiffness Measurement in Untreated Chronic Hepatitis B Patients

V. Wong, H. Chan, P. Lampertico, 2015, Digestive Diseases and Sciences.

231 PROGNOSTIC VALUE OF TRANSIENT ELASTOGRAPHY AND NON-INVASIVE MARKERS OF FIBROSIS IN PATIENTS WITH CHRONIC LIVER DISEASE. A PROSPECTIVE ANALYSIS OF 4,935 PERSON-YEARS

P. Couzigou, J. Font, J. Vergniol, 2009 .

Liver Stiffness Measurement With FibroScan: Use the Right Probe in the Right Conditions!

V. de Lédinghen, G. Hunault, F. Oberti, 2019, Clinical and translational gastroenterology.

Interferon‐gamma with peginterferon alpha‐2a and ribavirin in nonresponder patients with chronic hepatitis C (ANRS HC16 GAMMATRI)

P. Couzigou, P. Marcellin, G. Chêne, 2013, Journal of gastroenterology and hepatology.

Treatment with Bulevirtide in patients with chronic HBV/HDV co-infection. Safety and efficacy at month 18 in real-world settings

V. de Lédinghen, T. Asselah, X. Causse, 2022, Journal of Hepatology.

564 Evaluation of fibrosis regression using fibroscan in HCV responder patients. A prospective controlled study

P. Couzigou, L. Castéra, J. Foucher, 2006 .

Ribavirin posology, observance, and sustained virologic response.

V. de Lédinghen, P. Couzigou, L. Castéra, 2008, Clinical Gastroenterology and Hepatology.

Survival in infection‐related acute‐on‐chronic liver failure is defined by extrahepatic organ failures

K. Reddy, P. Kamath, S. Biggins, 2014, Hepatology.

[Spinocellular degeneration of an HPV 6 Buschke-Loewenstein tumor. Discussion of the concept of verrucous carcinoma].

J. Foucher, G. Guillet, J. L. le Roy, 1988, Annales de dermatologie et de vénéréologie.

A New Combination of Blood Test and Fibroscan for Accurate Non-Invasive Diagnosis of Liver Fibrosis Stages in Chronic Hepatitis C

V. de Lédinghen, S. Bertrais, F. Oberti, 2017 .

Validity and reliability measures of the Swedish Karolinska version of the Edinburgh Cognitive and Behavioral ALS Screen (SK-ECAS)

P. Andersen, D. Lulé, J. Pereira, 2023, Amyotrophic lateral sclerosis & frontotemporal degeneration.

A New Combination of Blood Test and Fibroscan for Accurate Non-Invasive Diagnosis of Liver Fibrosis Stages in Chronic Hepatitis C

S. Bertrais, F. Oberti, P. Calès, 2011, The American Journal of Gastroenterology.

Survival in infection‐related acute‐on‐chronic liver failure is defined by extrahepatic organ failures

K. Reddy, P. Kamath, S. Biggins, 2014, Hepatology.

Feasibility of liver transient elastography with FibroScan® using a new probe for obese patients

V. de Lédinghen, V. Rigalleau, J. Vergniol, 2010, Liver international : official journal of the International Association for the Study of the Liver.

Changes of non‐invasive markers and FibroScan values during HCV treatment

P. Couzigou, L. Castéra, J. Vergniol, 2009, Journal of viral hepatitis.

P. Couzigou, P. Marcellin, G. Chêne, 2010, Journal of medical virology.

2014 French guidelines for hepatitis B and C screening. A combined targeted and mass testing strategy of chronic viruses namely HBV, HCV and HIV

Y. Yazdanpanah, F. Roudot-thoraval, D. Dhumeaux, 2016 .

Impaired health-related quality of life in the HCV cure era: who is concerned? (ANRS CO22 HEPATHER French cohort)

V. de Lédinghen, J. Zucman‐Rossi, D. Thabut, 2023, Quality of Life Research.

Treatment With Bulevirtide in HIV Infected patients With chronic Hepatitis Delta. ANRS HD EP01 BULEDELTA & Compassionate Cohort

V. de Lédinghen, O. Chazouilleres, C. Gaudy-Graffin, 2024, JHEP Reports.

HDV-RNA decline less than 1 log after 6 months of BLV 2 mg monotherapy could define poor-response and lead to therapeutic decision. Data from real-life cohort

V. de Lédinghen, T. Asselah, X. Causse, 2023, Journal of Hepatology.

Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection

J. Foucher, V. Ledinghen, J. García-Samaniego, 2009, Journal of viral hepatitis.

Ultraportable Quantitative Ultrasound for Hepatic Steatosis Assessment.

J. Gay, C. Cohen-Bacrie, J. Foucher, 2024, Ultrasound in medicine & biology.